Recursion Pharmaceuticals, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Recursion Pharmaceuticals, Inc. - overview
Established
2013
Location
Salt Lake City, UT, US
Primary Industry
Software
About
Founded in 2013 and based in Utah, US, Recursion Pharmaceuticals, Inc. operates as a biotechnology company. The company was co-founded by CEO Chris Gibson, Blake Borgeson, and Dean Li. Recursion Pharmaceuticals, Inc.
trades on the NASDAQ GS under the ticker symbol RXRX, and in May 2023, the company acquired Cyclica, and Valence. In July 2023, the firm raised USD 50 million in PIPE funding from NVIDIA Corporation. Recursion Pharmaceuticals utilizes an AI-based using machine learning robotics platform in testing various compounds on cellular disease models which helps in discovering new treatments. Recursion Pharmaceuticals combines an advanced infrastructure layer to generate proprietary biological and chemical datasets and the Recursion Map, a suite of custom software, algorithms, and machine learning tools that the company uses to explore foundational biology and navigate to new biological insights.
The company plans to use the July 2023 funding to speed up the development of its platform.
Current Investors
EPIC Ventures, Lux Capital, Wild Basin Investments
Primary Industry
Software
Sub Industries
Biopharmaceuticals, Molecular Science, Genetics & Gene Therapy, Pharmaceutical Research & Development, Operating Systems (OS), Medical Software
Website
www.recursion.com
Verticals
Artificial Intelligence, Cloud Computing, HealthTech, Robotics
Company Stage
Mature
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.